SAB Biotherapeutics Inc.
(SABS)
undefined
undefined%
At close: undefined
4.08
1.24%
After-hours Dec 13, 2024, 04:00 PM EST
Ratios (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
PE Ratio | -0.23 | -0.34 | -3.06 | 3.20 | -117.14 |
PS Ratio | 4.24 | 0.27 | 0.88 | 1.17 | 320.52 |
PB Ratio | 0.17 | 0.21 | 1.38 | 1.65 | -478.48 |
P/FCF Ratio | -0.38 | -0.89 | -7.43 | -23.63 | -112.30 |
P/OCF Ratio | -0.38 | 1.71 | 14.20 | 6.44 | -119.72 |
OCF/S Ratio | -2.80 | 0.04 | 0.02 | 0.05 | -0.67 |
Debt / Equity Ratio | 0.01 | 0.02 | 0.01 | 0.00 | -0.22 |
Quick Ratio | 1.36 | 0.37 | 0.49 | 0.78 | 0.50 |
Current Ratio | 1.36 | 0.37 | 0.49 | 0.78 | 0.50 |
Asset Turnover | 0.03 | 0.47 | 0.77 | 0.98 | 0.19 |
Interest Coverage | -30.19 | -23.97 | -11.37 | 10.95 | -5.06 |
Return on Equity (ROE) | -73.64% | -60.34% | -45.25% | 51.57% | 408.46% |
Return on Assets (ROA) | -50.27% | -36.82% | -21.98% | 35.58% | -52.31% |
Return on Capital (ROIC) | -52.07% | -80.52% | -24.49% | 45.20% | -64.80% |
Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Profit Margin | -16.82% | 21.56% | 24.32% | 25.00% | 25.00% |
Net Profit Margin | -471.13% | -19.60% | -7.16% | 9.11% | -68.40% |